Harvard Bioscience, Inc.
- Industry Medical Instruments & Supplies
- Sector Healthcare
- Market Cap
- Earnings
About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
HBIO
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Harvard Bioscience Non-GAAP EPS of $0.04 misses by $0.01, revenue of $28.2M misses by $0.4M
- Harvard Bioscience Q4 2023 Earnings Preview
- Harvard Bioscience Non-GAAP EPS of $0.01 misses by $0.03, revenue of $25.4M misses by $2.5M
- Harvard Bioscience signs deal to sell Etisense's physiological monitoring solution in North America and Europe
- Harvard Bioscience Non-GAAP EPS of $0.04 misses by $0.02, revenue of $28.2M misses by $1.3M
- Harvard Bioscience to join Russell 2000 and Russell 3000 indexes
- Harvard Bioscience appoints CFO
- Harvard Bioscience Non-GAAP EPS of $0.06 beats by $0.02, revenue of $29.98M beats by $1.53M
- Harvard Bioscience Non-GAAP EPS of $0.04 beats by $0.03, revenue of $28.4M misses by $1.75M
- Harvard Bioscience announces CFO transistion
- Harvard Bioscience Non-GAAP EPS of -$0.01, revenue of $76.9M
- Harvard Bioscience GAAP EPS of $0.05 beats by $0.06, revenue of $29.2M misses by $1.2M
- Harvard Bioscience Non-GAAP EPS of $0.04 misses by $0.02, revenue of $28.78M beats by $0.05M
- Harvard Bioscience Non-GAAP EPS of $0.08 misses by $0.03, revenue of $33.1M in-line
- Harvard Bioscience EPS in-line, beats on revenue
- Harvard Bioscience EPS misses by $0.10, beats on revenue
- Harvard Bioscience EPS beats by $0.02, beats on revenue
- Harvard Bioscience EPS beats by $0.01, beats on revenue
- Harvard Bioscience secures $65M in new debt facility
- Harvard Bioscience EPS beats by $0.02, beats on revenue